​

PROCEPT BioRobotics (PRCT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PRCT Stock Forecast

PROCEPT BioRobotics (PRCT) stock forecast, based on 16 Wall Street analysts, predicts a 12-month average price target of $23.00, with a high of $30.00 and a low of $19.00. This represents a 16.16% increase from the last price of $19.80.

$15 $19 $23 $27 $31 $35 High: $30 Avg: $23 Low: $19 Last Closed Price: $19.8

PRCT Stock Rating

PROCEPT BioRobotics stock's rating consensus is Buy, based on 16 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (56.25%), 6 Hold (37.50%), 1 Sell (6.25%), and 0 Strong Sell (0.00%).

Buy
Total 16 0 1 6 9 Strong Sell Sell Hold Buy Strong Buy

PRCT Price Target Upside V Benchmarks

TypeNameUpside
StockPROCEPT BioRobotics16.16%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks17.44%

Price Target Trends

1M3M12M
# Anlaysts1720
Avg Price Target$30.00$22.57$33.85
Last Closing Price$19.80$19.80$19.80
Upside/Downside51.52%13.99%70.96%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 26139-114
Sep, 26139-114
Aug, 26157-114
Jul, 26165-113
Jun, 26164-112
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 06, 2026Christopher PasqualeBarclays$30.00$17.5171.33%51.52%
Aug 05, 2026Truist Financial$21.00$18.2714.94%6.06%
Aug 05, 2026Evercore ISI$23.00$18.6323.46%16.16%
Aug 05, 2026Robert W. Baird$20.00$18.289.41%1.01%
Aug 05, 2026Piper Sandler$25.00$18.2836.76%26.26%
Aug 05, 2026Nathan TreybeckWells Fargo$19.00$18.283.94%-4.04%
Aug 05, 2026Michael SarconeJefferies$20.00$18.647.30%1.01%
Jul 28, 2026UBS$20.00$17.6913.06%1.01%
Jul 02, 2026Truist Financial$25.00$21.0318.88%26.26%
Jun 24, 2026Vijay KumarEvercore ISI$30.00$20.6045.63%51.52%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 06, 2026BarclaysOverweightinitialise
Sep 09, 2026OppenheimerPerformPerformhold
Aug 05, 2026Cowen & Co.BuyBuyhold
Aug 05, 2026Piper SandlerOverweightOverweighthold
Aug 05, 2026JefferiesHoldHoldhold
Aug 05, 2026William BlairOutperformMarket Performdowngrade
Jul 28, 2026UBSBuyNeutraldowngrade
Jul 02, 2026CitigroupHolddowngrade
Jun 24, 2026Evercore ISIOutperforminitialise
Apr 30, 2026Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 $2 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.37$-1.96$-2.24$-1.75$1.24---
Avg Forecast$-3.04$-1.88$-2.14$-1.74$-1.30$-0.76$-0.02$0.56
High Forecast$-2.93$-1.81$-2.08$-1.69$-1.04$-0.56$-0.02$0.58
Low Forecast$-3.12$-1.95$-2.23$-1.83$-1.55$-1.05$-0.02$0.54
Surprise %-54.93%4.26%4.67%0.57%-195.38%---

Revenue Forecast

$0 $130M $260M $390M $520M $650M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$34.47M$75.01M$136.19M$224.50M$308.05M---
Avg Forecast$33.37M$74.15M$134.44M$223.93M$315.00M$415.28M$516.98M$624.64M
High Forecast$34.07M$76.43M$138.14M$224.04M$318.36M$416.43M$528.59M$641.83M
Low Forecast$32.44M$72.02M$129.50M$223.77M$311.07M$414.13M$505.38M$601.68M
Surprise %3.31%1.16%1.30%0.25%-2.21%---

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-59.85M$-87.15M$-105.90M$-91.41M$-95.57M---
Avg Forecast$-143.66M$-88.84M$-101.72M$-83.22M$-70.45M$-43.55M$-1.10M$26.62M
High Forecast$-138.46M$-85.51M$-98.19M$-79.93M$-49.23M$-26.33M$-1.05M$27.57M
Low Forecast$-147.59M$-92.38M$-105.24M$-86.51M$-73.37M$-49.54M$-1.14M$25.35M
Surprise %-58.34%-1.90%4.11%9.85%35.66%---

PRCT Forecast FAQ

Is PROCEPT BioRobotics stock a buy?

PROCEPT BioRobotics stock has a consensus rating of Buy, based on 16 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 6 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that PROCEPT BioRobotics is a favorable investment for most analysts.

What is PROCEPT BioRobotics's price target?

PROCEPT BioRobotics's price target, set by 16 Wall Street analysts, averages $23 over the next 12 months. The price target range spans from $19 at the low end to $30 at the high end, suggesting a potential 16.16% change from the previous closing price of $19.8.

How does PROCEPT BioRobotics stock forecast compare to its benchmarks?

PROCEPT BioRobotics's stock forecast shows a 16.16% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (17.44%).

What is the breakdown of analyst ratings for PROCEPT BioRobotics over the past three months?

  • October 2026: 7.14% Strong Buy, 21.43% Buy, 64.29% Hold, 0% Sell, 7.14% Strong Sell.
  • September 2026: 7.14% Strong Buy, 21.43% Buy, 64.29% Hold, 0% Sell, 7.14% Strong Sell.
  • August 2026: 7.14% Strong Buy, 35.71% Buy, 50.00% Hold, 0% Sell, 7.14% Strong Sell.

What is PROCEPT BioRobotics’s EPS forecast?

PROCEPT BioRobotics's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.76, marking a -161.29% decrease from the reported $1.24 in 2025. Estimates for the following years are $-0.02 in 2027, and $0.56 in 2028.

What is PROCEPT BioRobotics’s revenue forecast?

PROCEPT BioRobotics's average annual revenue forecast for its fiscal year ending in December 2026 is $415.28M, reflecting a 34.81% increase from the reported $308.05M in 2025. The forecast for 2027 is $516.98M, and $624.64M for 2028.

What is PROCEPT BioRobotics’s net income forecast?

PROCEPT BioRobotics's net income forecast for the fiscal year ending in December 2026 stands at $-43.549M, representing a -54.43% decrease from the reported $-95.573M in 2025. Projections indicate $-1.096M in 2027, and $26.62M in 2028.